AAMU
BIO icon

APG Asset Management US’s Bio-Rad Laboratories Class A BIO Stock Holding History

APG Asset Management US’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,093
Closed -$1.61M – 164
2024
Q2 		$1.61M Hold
6,093
– – 0.01% 164
2024
Q1 		$2.07M Buy
6,093
+1,930
+46% +$635K 0.01% 170
2023
Q4 		$1.34M Buy
+4,163
New +$1.3M 0.01% 185

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

APG Asset Management US's BIO Position: Q3 2024 in Review

APG Asset Management US sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2024, closing a stake of 6,093 shares — an estimated $1.61M sold.

APG Asset Management US first reported a position in BIO in Q4 2023 and held it in 3 quarters. The position peaked at $2.07M in Q1 2024. 437 funds tracked by Wall St. Rank hold BIO as of Q3 2024.

  • APG Asset Management US reported no remaining Bio-Rad Laboratories Class A position as of Q3 2024 after selling out during the quarter.
  • APG Asset Management US sold 6,093 Bio-Rad Laboratories Class A shares in Q3 2024, an estimated $1.61M.
  • APG Asset Management US first reported a position in Bio-Rad Laboratories Class A in Q4 2023 and held it in 3 quarters.
  • APG Asset Management US's Bio-Rad Laboratories Class A position peaked at $2.07M in Q1 2024.
  • 437 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2024.

Based on APG Asset Management US's 13F filing for Q3 2024, filed 14 Nov 2024.